1. Home
  2. Analysis
  3. Lamisil
  4. Tranxene

Lamisil and Tranxene drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lamisil (terbinafine hydrochloride) and Tranxene (clorazepate dipotassium). Common drug interactions include type 2 diabetes mellitus among females and activated partial thromboplastin time prolonged among males.

The phase IV clinical study analyzes what interactions people have when they take Lamisil and Tranxene. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Lamisil?

Lamisil has active ingredients of terbinafine hydrochloride. It is often used in pulmonary aspergilloma (mycetoma). eHealthMe is studying from 14,080 Lamisil users. Check the latest studies of Lamisil.

What is Tranxene?

Tranxene has active ingredients of clorazepate dipotassium. It is often used in stress and anxiety. eHealthMe is studying from 6,550 Tranxene users. Check the latest studies of Tranxene.

On Jul, 25, 2026

14 people who take Lamisil and Tranxene together, and have interactions are studied.

Lamisil and Tranxene drug interactions.

What are the common drug interactions of Lamisil and Tranxene, by gender? *:

female:

  1. Type 2 diabetes mellitus
  2. Arthralgia (joint pain)
  3. Diarrhoea
  4. Chest pain
  5. Cough
  6. Dental caries
  7. Depression
  8. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  9. Drug dependence
  10. Dyspepsia (indigestion)

male:

  1. Activated partial thromboplastin time prolonged
  2. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  3. Haematoma (collection of blood outside the blood vessels)
  4. Hemiplegia (paralysis of one side of the body)
  5. Injury
  6. Ischaemic stroke (stroke; caused by an interruption in the flow of blood to the brain)
  7. Migraine (headache)
  8. Nervous system disorder (a general class of medical conditions affecting the nervous system)
  9. Pain
  10. Paralysis

What are the common drug interactions of Lamisil and Tranxene, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Arthralgia (joint pain)
  2. Chest pain
  3. Cough
  4. Dental caries
  5. Depression
  6. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  7. Diarrhoea
  8. Drug dependence
  9. Dyspepsia (indigestion)
  10. Dyspnoea (difficult or laboured respiration)

40-49:

  1. Activated partial thromboplastin time prolonged
  2. Blood bilirubin increased
  3. Haematoma (collection of blood outside the blood vessels)
  4. Hepatitis (inflammation of the liver)
  5. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  6. Nausea (feeling of having an urge to vomit)
  7. Pruritus (severe itching of the skin)
  8. Vomiting

50-59:

  1. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  2. Death
  3. Pneumonia
  4. Type 2 diabetes mellitus
  5. Arthralgia (joint pain)
  6. Back pain
  7. Muscle strain (an injury to a muscle in which the muscle fibres tear)
  8. Rash

60+:

  1. Pain
  2. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  3. Diarrhoea
  4. Dysphasia (language disorder marked by deficiency in the generation of speech)
  5. Dysstasia (difficulty in standing)
  6. Fall
  7. Fear
  8. Femoral neck fracture (neck of femur bone fracture)
  9. Haemoglobin decreased
  10. Hemiplegia (paralysis of one side of the body)

What are the existing conditions these people have? *

  1. Pain: 2 people, 14.29%
  2. Depression: 2 people, 14.29%
  3. Quit Smoking: 1 person, 7.14%
  4. Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur): 1 person, 7.14%
  5. Nasopharyngitis (inflammation of the nasopharynx): 1 person, 7.14%
  6. Insomnia (sleeplessness): 1 person, 7.14%
  7. Hypertriglyceridaemia (excess of triglycerides in the blood): 1 person, 7.14%
  8. Fungal Nail Infection: 1 person, 7.14%
  9. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 7.14%
  10. Agitation (state of anxiety or nervous excitement): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Lamisil and Tranxene?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lamisil and Tranxene:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lamisil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tranxene:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lamisil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tranxene and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on terbinafine hydrochloride and clorazepate dipotassium (the active ingredients of Lamisil and Tranxene, respectively), and Lamisil and Tranxene (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.